IOVA ▼ -9.2% - Iovance Biotherapeutics, Inc.
$IOVA - Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)
29-OCT-2026 07:00 AM ET
Share this post
More filings for $IOVA
IOVA ▲ +13.2% - Iovance Biotherapeutics, Inc.Oct 28, 2026IOVA ▲ +0.1% - Iovance Biotherapeutics, Inc.Oct 27, 2026IOVA ▲ +2.0% - Iovance Biotherapeutics, Inc.Oct 26, 2026IOVA ▼ -2.6% - Iovance Biotherapeutics, Inc.Oct 23, 2026IOVA ▼ -0.7% - Iovance Biotherapeutics, Inc.Oct 19, 2026IOVA ▲ +0.2% - Iovance Biotherapeutics, Inc.Oct 1, 2026
View full $IOVA filing history →💬 Comments
Loading comments…
Leave a comment